Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
NCT ID: NCT06201494
Last Updated: 2024-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2023-01-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Hospitalization of Children With Bronchial Asthma
NCT05800379
Clinical Characteristics of Severe Childhood Asthma
NCT06024902
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162
The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children
NCT01144910
Fluctuation of Airway Function in Children With Asthma
NCT02252289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In practice, however, it is also possible to see children whose asthma initially manifests as conditions assessed as recurrent pneumonia, isolated chronic cough of a moist nature or as inspiratory dyspnoea. These atypical symptoms are not oficially counted as asthma symptoms. In this study, the investigators focus on prevalence of typical and atypical asthma symtpoms. Furthermore, the investigators study sensitivity of offical asthma symptom questinaire ISAAC in children with typical and atypical asthma symptoms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jana Tuková
MUDr, Phd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jana Tukova, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Charles University, Czech Republic First Faculty of Medicine, Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First faculty of Medicine, Charles university.
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CZ-VFN-PEDMET-ASTHMA-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.